FGF21 and fatty liver disease: Therapeutic administration of recombinant FGF21 exerts a variety of beneficial effects in rodents and nonhuman primates, including reduction of adiposity and alleviation of hyperglycemia, insulin resistance, dyslipidemia, and fatty liver disease [21].